{"id":"https://openalex.org/W4413774696","doi":"https://doi.org/10.1200/oa-25-00095","title":"Reply to: Concerns About the Efficacy and External Validity of Efbemalenograstim Alfa","display_name":"Reply to: Concerns About the Efficacy and External Validity of Efbemalenograstim Alfa","publication_year":2025,"publication_date":"2025-08-01","ids":{"openalex":"https://openalex.org/W4413774696","doi":"https://doi.org/10.1200/oa-25-00095"},"language":"en","primary_location":{"id":"doi:10.1200/oa-25-00095","doi":"https://doi.org/10.1200/oa-25-00095","is_oa":true,"landing_page_url":"https://doi.org/10.1200/oa-25-00095","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/OA-25-00095","source":{"id":"https://openalex.org/S4404662432","display_name":"JCO oncology advances.","issn_l":"2994-9750","issn":["2994-9750"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315860","host_organization_name":"Wolters Kluwer Health","host_organization_lineage":["https://openalex.org/P4310315860","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer Health","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Oncology Advances","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ascopubs.org/doi/pdf/10.1200/OA-25-00095","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":["John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC"],"raw_orcid":"https://orcid.org/0000-0002-1800-9076","affiliations":[{"raw_affiliation_string":"John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019547742","display_name":"Igor Bondarenko","orcid":"https://orcid.org/0000-0002-7071-2471","observed_orcids":["https://orcid.org/0000-0002-7071-2471"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Bondarenko","raw_affiliation_strings":["John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC"],"raw_orcid":"https://orcid.org/0000-0002-7071-2471","affiliations":[{"raw_affiliation_string":"John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012700479","display_name":"Sergei Tjulandin","orcid":"https://orcid.org/0000-0001-9807-2229","observed_orcids":["https://orcid.org/0000-0001-9807-2229"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergei Tjulandin","raw_affiliation_strings":["John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC"],"raw_orcid":"https://orcid.org/0000-0001-9807-2229","affiliations":[{"raw_affiliation_string":"John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I184565670"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057509756","display_name":"Michael Auerbach","orcid":"https://orcid.org/0000-0003-0707-8647","observed_orcids":["https://orcid.org/0000-0003-0707-8647"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Auerbach","raw_affiliation_strings":["John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC"],"raw_orcid":"https://orcid.org/0000-0003-0707-8647","affiliations":[{"raw_affiliation_string":"John A. Glaspy, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; Igor Bondarenko, MD, PhD, Dnepropetrovsk Medical Academy, Oncology, Dnepropetrovsk, Ukraine; Sergei Tjulandin, MD, Blokhin National Medical Research Center for Oncology, Moscow, Russia; and Michael Auerbach, MD, Auerbach Hematology and Oncology, Baltimore, MD, Georgetown University School of Medicine, Washington, DC","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I184565670"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.8220000267028809},{"id":"https://openalex.org/keywords/severe-neutropenia","display_name":"severe neutropenia","score":0.7429999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relative-dose-intensity","display_name":"relative dose intensity","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6990000009536743},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.6349999904632568},{"id":"https://openalex.org/keywords/generalizability","display_name":"generalizability","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C174106493","wikidata":"https://www.wikidata.org/wiki/Q1057880","display_name":"External validity","level":2,"score":0.5771900415420532},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5750220417976379},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.31944721937179565}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/oa-25-00095","doi":"https://doi.org/10.1200/oa-25-00095","is_oa":true,"landing_page_url":"https://doi.org/10.1200/oa-25-00095","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/OA-25-00095","source":{"id":"https://openalex.org/S4404662432","display_name":"JCO oncology advances.","issn_l":"2994-9750","issn":["2994-9750"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315860","host_organization_name":"Wolters Kluwer Health","host_organization_lineage":["https://openalex.org/P4310315860","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer Health","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Oncology Advances","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/oa-25-00095","doi":"https://doi.org/10.1200/oa-25-00095","is_oa":true,"landing_page_url":"https://doi.org/10.1200/oa-25-00095","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/OA-25-00095","source":{"id":"https://openalex.org/S4404662432","display_name":"JCO oncology advances.","issn_l":"2994-9750","issn":["2994-9750"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315860","host_organization_name":"Wolters Kluwer Health","host_organization_lineage":["https://openalex.org/P4310315860","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer Health","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Oncology Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4413774696.pdf","grobid_xml":"https://content.openalex.org/works/W4413774696.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W2050242888","https://openalex.org/W4382182862","https://openalex.org/W4386093382","https://openalex.org/W4389836815","https://openalex.org/W4390781785","https://openalex.org/W4402525044","https://openalex.org/W4408424986","https://openalex.org/W4413774704"],"related_works":["https://openalex.org/W7129341177","https://openalex.org/W4220982811","https://openalex.org/W4414995906","https://openalex.org/W4402525044","https://openalex.org/W7167352377","https://openalex.org/W4390781785","https://openalex.org/W4408424986","https://openalex.org/W4412415852","https://openalex.org/W4389836815","https://openalex.org/W7161643415"],"abstract_inverted_index":{"We":[0],"appreciate":[1],"Dr":[2],"Suto's":[3],"1":[4,126],"comments":[5],"on":[6],"our":[7],"recently":[8],"published":[9],"article.":[10],"2":[11,85,90],"For":[12],"his":[13],"first":[14],"concern":[15],"that":[16,49],"the":[17,32,40,59,71,77,115,133,146,154,158,166,177,185,189,200],"lower":[18,128,178],"rate":[19,179],"of":[20,37,74,81,104,114,118,130,141,180,194,199,203],"severe":[21,181],"neutropenia":[22,182],"observed":[23],"in":[24,53,124,132,145,153,184],"late":[25,190],"chemotherapy":[26,38,56,82,101,191,204],"cycles":[27,57],"might":[28],"be":[29],"influenced":[30],"by":[31],"relative":[33],"dose":[34,80,108,117],"intensity":[35],"(RDI)":[36],"and":[39,62,87],"investigator's":[41],"arbitrary":[42],"decision,":[43],"we":[44],"would":[45],"like":[46],"to":[47,66,173,176],"confirm":[48],"RDI":[50,92,140,152,162,170],"was":[51,171],"comparable":[52,164],"all":[54,99],"four":[55,100],"between":[58],"treatment":[60,68,168],"arms":[61],"investigators":[63],"were":[64,163],"blinded":[65],"patient's":[67],"assignment":[69],"during":[70,98,188],"study.The":[72],"majority":[73],"patients":[75,105,131,195],"received":[76,112,138,197],"full":[78,116,201],"intended":[79],"(75":[83],"mg/m":[84,89],"docetaxel":[86,119,142],"600":[88],"cyclophosphamide,":[91],">90%)":[93],"once":[94],"every":[95],"3":[96],"weeks":[97],"cycles.The":[102],"percentage":[103,129],"who":[106,111,196],"required":[107],"reduction":[109],"(patients":[110],"\u226490%":[113,139,198],"or":[120],"cyclophosphamide)":[121],"is":[122],"shown":[123],"Table":[125],"below.A":[127],"F-627":[134,155,186],"(efbemalenograstim":[135],"alfa)":[136],"arm":[137,149,187],"than":[143],"those":[144],"Neulasta":[147],"(pegfilgrastim)":[148],"(suggesting":[150],"higher":[151],"arm),":[156],"whereas":[157],"percentages":[159],"for":[160,165],"cyclophosphamide":[161],"two":[167],"arms.Therefore,":[169],"unlikely":[172],"have":[174],"contributed":[175],"seen":[183],"cycle.a":[192],"%":[193],"doses":[202],"drugs.":[205]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2025-10-10T00:00:00"}